Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors

Science Translational Medicine

Volumn 5, Issue 172, 2013, Pages

  Sandoval, Federico ^a,b   Terme, Magali ^a,b   Nizard, Mevyn ^a,b   Badoual, Cécile ^a,b,c   Bureau, Michel Francis ^d   Freyburger, Ludovic ^e   Clement, Olivier ^a,b   Marcheteau, Elie ^a,b,f,g   Gey, Alain ^c   Fraisse, Guillaume ^a,b   Bouguin, Cécilia ^a,b   Merillon, Nathalie ^a,b   Dransart, Estelle ^h,i   Tran, Thi ^a,b   Quintin Colonna, Françoise ^a,b,e   Autret, Gwennhael ^a,b   Thiebaud, Marine ^h,i   Suleman, Muhammed ^j   Riffault, Sabine ^k   Wu, Tzyy Choou ^l   Launay, Odile ^f,g   Danel, Claire ^m   Taieb, Julien ^a,b,c   Richardson, Jennifer ^j   Zitvogel, Laurence ⁿ   Fridman, Wolf H ^b,c   Johannes, Ludger ^h,i   Tartour, Eric ^a,b,c,f   more..

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d CNRS   (France)

^e ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^f INSERM   (France)

^g Institut Cochin   (France)

^h INSTITUT CURIE   (France)

ⁱ INSTITUT CURIE   (France)

^j INRA   (France)

^k INRA Institut National de la Recherche Agronomique   (France)

^l DEPARTMENT OF PATHOLOGY   (United States)

^m BICHAT HOSPITAL   (France)

ⁿ University Paris XI   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; CANCER VACCINE; CD103 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CD8+ T LYMPHOCYTE; CELL HOMING; CELL INFILTRATION; COCULTURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, CD; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, MUCOSAL; INJECTIONS, INTRAMUSCULAR; INTEGRIN ALPHA CHAINS; INTEGRIN ALPHA1; LUNG NEOPLASMS; LYMPH NODES; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; NASAL MUCOSA; PAPILLOMAVIRUS VACCINES; SHIGA TOXINS; SPLEEN; TUMOR BURDEN;

EID: 84874028719     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004888     Document Type: Article

References (54)

1. T. Boon, P. G. Coulie, B. J. Van den Eynde, P. van der Bruggen, Human T cell responses against melanoma. Annu. Rev. Immunol. 24, 175-208 (2006).
2. W. H. Fridman, J. Galon, F. Pagès, E. Tartour, C. Sautès-Fridman, G. Kroemer, Prognostic and predictive impact of intra-and peritumoral immune infiltrates. Cancer Res. 71, 5601-5605 (2011).
3. E. K. Broussard, M. L. Disis, TNM staging in colorectal cancer: T is for T cell and M is for memory. J. Clin. Oncol. 29, 601-603 (2011).
4. P. W. Kantoff, C. S. Higano, N. D. Shore, E. R. Berger, E. J. Small, D. F. Penson, C. H. Redfern, A. C. Ferrari, R. Dreicer, R. B. Sims, Y. Xu, M. W. Frohlich, P. F. Schellhammer; IMPACT Study Investigators, Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363, 411-422 (2010).
5. D. J. Schwartzentruber, D. H. Lawson, J. M. Richards, R. M. Conry, D. M. Miller, J. Treisman, F. Gailani, L. Riley, K. Conlon, B. Pockaj, K. L. Kendra, R. L. White, R. Gonzalez, T. M. Kuzel, B. Curti, P. D. Leming, E. D. Whitman, J. Balkissoon, D. S. Reintgen, H. Kaufman, F. M. Marincola, M. J. Merino, S. A. Rosenberg, P. Choyke, D. Vena, P. Hwu, gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N. Engl. J. Med. 364, 2119-2127 (2011).
6. G. G. Kenter, M. J. Welters, A. R. Valentijn, M. J. Lowik, D. M. Berends-van der Meer, A. P. Vloon, F. Essahsah, L. M. Fathers, R. Offringa, J. W. Drijfhout, A. R. Wafelman, J. Oostendorp, G. J. Fleuren, S. H. van der Burg, C. J. Melief, Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med. 361, 1838-1847 (2009).
7. E. Quoix, R. Ramlau, V. Westeel, Z. Papai, A. Madroszyk, A. Riviere, P. Koralewski, J. L. Breton, E. Stoelben, D. Braun, D. Debieuvre, H. Lena, M. Buyse, M. P. Chenard, B. Acres, G. Lacoste, B. Bastien, A. Tavernaro, N. Bizouarne, J. Y. Bonnefoy, J. M. Limacher, Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: A controlled phase 2B trial. Lancet Oncol. 12, 1125-1133 (2011).
8. C. Badoual, F. Sandoval, H. Pere, S. Hans, A. Gey, N. Merillon, C. Van Ryswick, F. Quintin-Colonna, P. Bruneval, D. Brasnu, W. H. Fridman, E. Tartour, Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 32, 946-958 (2010).
9. + T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
10. M. Ahmadzadeh, L. A. Johnson, B. Heemskerk, J. R. Wunderlich, M. E. Dudley, D. E. White, S. A. Rosenberg, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537-1544 (2009).
11. + T cells in the circulation but not in the tumor site. J. Immunol. 177, 1670-1678 (2006).
12. B. S. Sheridan, L. Lefrançois, Regional and mucosal memory T cells. Nat. Immunol. 12, 485-491 (2011).
13. C. Czerkinsky, J. Holmgren, Topical immunization strategies. Mucosal Immunol. 3, 545-555 (2010).
14. Y. Fujkuyama, D. Tokuhara, K. Kataoka, R. S. Gilbert, J. R. McGhee, Y. Yuki, H. Kiyono, K. Fujihashi, Novel vaccine development strategies for inducing mucosal immunity. Expert Rev. Vaccines 11, 367-379 (2012).
15. B. Vingert, O. Adotevi, D. Patin, S. Jung, P. Shrikant, L. Freyburger, C. Eppolito, A. Sapoznikov, M. Amessou, F. Quintin-Colonna, W. H. Fridman, L. Johannes, E. Tartour, The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur. J. Immunol. 36, 1124-1135 (2006).
16. N. Haicheur, E. Bismuth, S. Bosset, O. Adotevi, G. Warnier, V. Lacabanne, A. Regnault, C. Desaymard, S. Amigorena, P. Ricciardi-Castagnoli, B. Goud, W. H. Fridman, L. Johannes, E. Tartour, The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165, 3301-3308 (2000).
17. + T cells and tumor immunity against self antigens. Blood 118, 4853-4862 (2011).
18. O. Adotevi, B. Vingert, L. Freyburger, P. Shrikant, Y. C. Lone, F. Quintin-Colonna, N. Haicheur, M. Amessou, A. Herbelin, P. Langlade-Demoyen, W. H. Fridman, F. Lemonnier, L. Johannes, E. Tartour, B subunit of Shiga toxin-based vaccines synergize with α-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J. Immunol. 179, 3371-3379 (2007).
19. M. DuPage, A. F. Cheung, C. Mazumdar, M. M. Winslow, R. Bronson, L. M. Schmidt, D. Crowley, J. Chen, T. Jacks, Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell 19, 72-85 (2011).
20. W. S. Gallichan, K. L. Rosenthal, Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J. Exp. Med. 184, 1879-1890 (1996).
21. I. M. Belyakov, J. D. Ahlers, What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J. Immunol. 183, 6883-6892 (2009).
22. F. Lemiale, W. P. Kong, L. M. Akyürek, X. Ling, Y. Huang, B. K. Chakrabarti, M. Eckhaus, G. J. Nabel, Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J. Virol. 77, 10078-10087 (2003).
23. I. M. Belyakov, M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, J. A. Berzofsky, Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. U.S.A. 95, 1709-1714 (1998).
24. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102, 2072-2081 (1998).
25. + T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181, 4188-4198 (2008).
26. S. G. Hansen, C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, M. Piatak Jr., J. D. Lifson, J. A. Nelson, M. A. Jarvis, L. J. Picker, Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15, 293-299 (2009).
27. J. Liu, K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, G. Landucci, D. N. Forthal, D. C. Montefiori, A. Carville, K. G. Mansfield, M. J. Havenga, M. G. Pau, J. Goudsmit, D. H. Barouch, Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457, 87-91 (2009).
28. D. Masopust, D. Choo, V. Vezys, E. J. Wherry, J. Duraiswamy, R. Akondy, J. Wang, K. A. Casey, D. L. Barber, K. S. Kawamura, K. A. Fraser, R. J. Webby, V. Brinkmann, E. C. Butcher, K. A. Newell, R. Ahmed, Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 207, 553-564 (2010).
29. + CTLs in delay of AIDS viral dissemination from mucosa. Blood 107, 3258-3264 (2006).
30. + T cells. J. Immunol. 178, 7211-7221 (2007).
31. S. J. Ray, S. N. Franki, R. H. Pierce, S. Dimitrova, V. Koteliansky, A. G. Sprague, P. C. Doherty, A. R. de Fougerolles, D. J. Topham, The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20, 167-179 (2004).
32. + effector T cells from apoptosis during influenza infection. J. Immunol. 179, 5054-5063 (2007).
33. J. R. Mora, U. H. von Andrian, T-cell homing specificity and plasticity: New concepts and future challenges. Trends Immunol. 27, 235-243 (2006).
34. D. J. Zammit, D. L. Turner, K. D. Klonowski, L. Lefrançois, L. S. Cauley, Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24, 439-449 (2006).
35. + T cells to be activated by residual antigen. J. Exp. Med. 207, 1153-1160 (2010).
36. T. S. Kim, J. Sun, T. J. Braciale, T cell responses during influenza infection: Getting and keeping control. Trends Immunol. 32, 225-231 (2011).
37. K. D. Klonowski, K. J. Williams, A. L. Marzo, D. A. Blair, E. G. Lingenheld, L. Lefrançois, Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 20, 551-562 (2004).
38. K. H. Ely, T. Cookenham, A. D. Roberts, D. L. Woodland, Memory T cell populations in the lung airways are maintained by continual recruitment. J. Immunol. 176, 537-543 (2006).
39. + T cells specific for respiratory viruses in the human lung. J. Exp. Med. 202, 1433-1442 (2005).
40. T. Calzascia, F. Masson, W. Di Berardino-Besson, E. Contassot, R. Wilmotte, M. Aurrand-Lions, C. Rüegg, P. Y. Dietrich, P. R. Walker, Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22, 175-184 (2005).
41. D. W. Mullins, S. L. Sheasley, R. M. Ream, T. N. Bullock, Y. X. Fu, V. H. Engelhard, Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 198, 1023-1034 (2003).
42. C. Bourquin, P. von der Borch, C. Zoglmeier, D. Anz, N. Sandholzer, N. Suhartha, C. Wurzenberger, A. Denzel, R. Kammerer, W. Zimmermann, S. Endres, Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model. J. Immunol. 185, 2580-2588 (2010).
43. L. Decrausaz, S. Domingos-Pereira, M. Duc, M. Bobst, P. Romero, J. T. Schiller, P. Jichlinski, D. Nardelli-Haefliger, Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus- associated genital tumors. Int. J. Cancer 129, 762-772 (2011).
44. N. Cuburu, M. N. Kweon, C. Hervouet, H. R. Cha, Y. Y. Pang, J. Holmgren, K. Stadler, J. T. Schiller, F. Anjuère, C. Czerkinsky, Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J. Immunol. 183, 7851-7859 (2009).
45. S. Kim-Schulze, H. S. Kim, A. Wainstein, D. W. Kim, W. C. Yang, D. Moroziewicz, P. Y. Mong, M. Bereta, B. Taback, Q. Wang, H. L. Kaufman, Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer. J. Immunol. 181, 8112-8119 (2008).
46. P. Berraondo, C. Nouzé, X. Préville, D. Ladant, C. Leclerc, Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Cancer Res. 67, 8847-8855 (2007).
47. P. J. Tacken, I. J. de Vries, R. Torensma, C. G. Figdor, Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802 (2007).
48. D. Sancho, O. P. Joffre, A. M. Keller, N. C. Rogers, D. Martínez, P. Hernanz-Falcón, I. Rosewell, C. Reise Sousa, Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899-903 (2009).
49. + T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. U.S.A. 105, 2574-2579 (2008).
50. N. Lycke, Recent progress in mucosal vaccine development: Potential and limitations. Nat. Rev. Immunol. 12, 592-605 (2012).
51. 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J. Exp. Med. 204, 559-570 (2007).
52. A. Thomas, R. Hassan, Immunotherapies for non-small-cell lung cancer and mesothelioma. Lancet Oncol. 13, e301-e310 (2012).
53. D. Kim, C. F. Hung, T. C. Wu, Monitoring the trafficking of adoptively transferred antigen-specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum. Gene Ther. 18, 575-588 (2007).
54. h1-dominant polarization. Int. Immunol. 15, 1161-1171 (2003).